Skip to content
value.today

Vascular Therapies LLC

Total raised
$77 M
6 rounds on record
Latest round
$24 M
Feb 2022
First round on record
Feb 2009
Today
Private
No later event on record

Funding rounds

6 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Vascular Therapies LLC
MonthRaisedRaiseSizeInvestorsSoldFiling
Feb 2022$24 MNo. 6$10 to $50 million

Vascular Therapies LLC: Raise no. 6, Feb 2022

Investors in this round

54 investors had bought by the notice of Mar 4, 2022: 54 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$24 M of $25 M offered; $1 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • John McDermott · Executive Officer, Director
  • Sriram Iyer · Executive Officer, Director
  • Allan Tessler · Director
  • Andrew Midler · Director
  • Daniel Ryan · Director
  • Gerald Dorros · Director
  • Robert Croce · Director
  • Robert Flanagan · Director
  • Somu Subramaniam · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by John McDermott, Chief Executive Officer. Newest notice filed Mar 4, 2022. Read the notice at the SEC.

equitySEC
Oct 2018$12 MNo. 5$10 to $50 million

Vascular Therapies LLC: Raise no. 5, Oct 2018

Investors in this round

29 investors had bought by the notice of Oct 12, 2018: 29 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$12 M of $21 M offered; $9 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Sriram Iyer · Executive Officer, Director
  • Allan Tessler · Director
  • Andrew Midler · Director
  • Dan Ryan · Director
  • Gerald Dorros · Director
  • Kiyoshi Takesue · Director
  • Robert Croce · Director
  • Robert Flanagan · Director
  • Somu Subramaniam · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Sriram Iyer, President. Newest notice filed Oct 12, 2018. Read the notice at the SEC.

equitySEC
Feb 2015$31 MNo. 4$10 to $50 million

Vascular Therapies LLC: Raise no. 4, Feb 2015

Investors in this round

33 investors had bought by the notice of Dec 30, 2016: 33 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$31 M of $31 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Sriram Iyer · Executive Officer, Director
  • Allan Tessler · Director
  • Gerald Dorros · Director
  • Kiyoshi Takesue · Director
  • Michael Bamberger · Director
  • Robert Croce · Director
  • Robert Flanagan · Director
  • Somu Subramaniam · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Sriram Iyer, Chairman and President. Newest notice filed Dec 30, 2016 (1 amendment). Read the notice at the SEC.

equitySEC
Jun 2012$5 MNo. 3$2 to $10 million

Vascular Therapies LLC: Raise no. 3, Jun 2012

Investors in this round

11 investors had bought by the notice of Jul 12, 2013: 11 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$5 M of $15 M offered; $10 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
more than a year
Issuer's revenue
Not disclosed
Sales commissions
$750,000
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks sales commissions as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Sriram Iyer · Executive Officer, Director
  • Allan Tessler · Director
  • Gerald Dorros · Director
  • Kiyoshi Takesue · Director
  • Michael Bamberger · Director
  • Robert Croce · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • ROBERTS MITANI, LLC (CRD 30022) · New York, New YorkSold in FL, NY

Signed by Sriram Iyer, M.D., Chairman and President. Newest notice filed Jul 12, 2013 (1 amendment). Read the notice at the SEC.

equitySEC
May 2011$3 MNo. 2$2 to $10 million

Vascular Therapies LLC: Raise no. 2, May 2011

Investors in this round

30 investors had bought by the notice of Jun 14, 2011: 30 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$3 M of $5 M offered; $2 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Limited Liability Company, incorporated in Delaware

People named in the notice

  • Paul M. Barkofsky · Executive Officer
  • Sriram M. Iyer · Executive Officer, Director
  • Gerald M. Dorros · Director
  • Michael M. Bamberger · Director
  • Robert M. Croce · Director
  • Samuel M. Liang · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Sriram Iyer, Executive Officer. Newest notice filed Jun 14, 2011. Read the notice at the SEC.

equitySEC
Feb 2009$1 MNo. 1Under $2 million

Vascular Therapies LLC: Raise no. 1, Feb 2009

Investors in this round

22 investors had bought by the notice of Apr 25, 2011: 22 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$1 M of $1 M offered
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Limited Liability Company, incorporated in Delaware

People named in the notice

  • Sriram M. Iyer · Executive Officer, Director
  • Gerald M. Dorros · Director
  • Michael M. Bamberger · Director
  • Paul M. Barkofsky · Director
  • Robert M. Croce · Director
  • Samuel M. Liang · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Sriram Iyer, Executive Officer. Newest notice filed Apr 25, 2011. Read the notice at the SEC.

debt, optionsSEC

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Vascular Therapies LLC chose not to state its revenue in its newest notice of a funding round (Mar 2022).

    SEC Form D · Mar 2022

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Mar 2022

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Vascular Therapies LLC is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Vascular Therapies LLC
NameRoleNamed in
John McDermottExecutive officerMar 2022
Sriram IyerExecutive officerMar 2022
Paul M. BarkofskyExecutive officerJun 2011
Sriram M. IyerExecutive officerJun 2011
Allan TesslerDirectorMar 2022
Andrew MidlerDirectorMar 2022
Daniel RyanDirectorMar 2022
Gerald DorrosDirectorMar 2022
John McDermottDirectorMar 2022
Robert CroceDirectorMar 2022
Robert FlanaganDirectorMar 2022
Somu SubramaniamDirectorMar 2022
Sriram IyerDirectorMar 2022
Dan RyanDirectorOct 2018
Kiyoshi TakesueDirectorOct 2018
Michael BambergerDirectorDec 2016
Gerald M. DorrosDirectorJun 2011
Michael M. BambergerDirectorJun 2011
Robert M. CroceDirectorJun 2011
Samuel M. LiangDirectorJun 2011
Sriram M. IyerDirectorJun 2011
Paul M. BarkofskyDirectorApr 2011